Related Experiment Video
Updated: Jun 3, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Treatment type 1 diabetes in children]
1Service d'endocrino-diabétologie pédiatrique, centre hospitalier de Versailles, Le Chesnay-Rocquencourt, France.
Type 1 diabetes in children is rising, requiring insulin therapy, diet, exercise, and education. Advanced tools like continuous glucose monitors and hybrid closed-loop systems improve management and reduce the burden of this chronic condition.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Type 1 diabetes is a growing concern in pediatric populations, necessitating comprehensive management strategies.
- Current care involves insulin therapy, nutritional guidance, physical activity, and patient/caregiver education.
- Blood glucose monitoring utilizes capillary tests or continuous glucose sensors for enhanced accuracy and comfort.
Purpose of the Study:
- To review current management approaches for pediatric Type 1 diabetes.
- To highlight advancements in insulin delivery and glucose monitoring technologies.
- To emphasize the potential benefits of early diagnosis and novel therapeutic strategies.
Main Methods:
- Review of current medical literature and clinical practices for pediatric Type 1 diabetes.
- Discussion of insulin delivery methods including pens, pumps, and functional insulin therapy.
- Exploration of continuous glucose monitoring and hybrid closed-loop systems.
Main Results:
- Continuous glucose monitoring offers improved comfort and accuracy over traditional methods.
- Hybrid closed-loop systems demonstrate efficacy in glycemic control and reducing patient burden.
- Early diagnosis of diabetes can prevent complications like diabetic ketoacidosis and improve long-term outcomes.
Conclusions:
- Integrated management combining technology and education is crucial for pediatric Type 1 diabetes.
- Technological advancements like hybrid closed-loop systems offer significant benefits for glycemic control.
- Preclinical diagnosis and timely intervention are key challenges and opportunities for future diabetes care.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes II: Pathophysiology
